In a 2013 publication, Gill et.al. sought to examine two things: the patterns of utilization of hypothermic machine perfusion (HMP) as a function of cold ischemic time (CIT) and donor type as well as the impact of HMP on the risk of DGF by CIT and donor type. They used data from the Scientific Registry of Transplant Recipients (SRTR) on all adult deceased donor kidney transplant recipients between January 1, 2000 and December 1, 2011 to complete their analysis.
The overall results of the analysis were:
- In standard criteria donors (SCD)
- The odds of DGF were lower with HMP compared to CS at all CIT
- In extended criteria donors (ECD)
- HMP use was associated with reduced risk of DGF when CIT is beyond 6 hours
- In donation after circulatory death (DCD) donors
- HMP use was associated with reduced risk of DGF when the CIT is between 6 and 24 hours
They summarized that their data confirmed the benefits of HMP use in reducing the risk of DGF irrespective of the donor type and CIT. They concluded that the best strategy to reduce the risk of DGF if to use HMP and minimize CIT in all deceased donor kidney transplants.
Read the full article here: https://doi.org/10.1097/01.tp.0000438637.29214.10
Check out the most recent posts
Moser et al. sought to determine whether the short warm ischemic time in living donor kidney (LDK) transplantation causes damage to the kidney, and whether these kidneys could benefit from the use of hypothermic machine perfusion (HMP). In their initial experiment,...
April 19, 2021 to April 22, 2021 2021 Virtual Transplant Management ForumTransplant administrators from across the country attend the UNOS Transplant Management Forum each year for its educational sessions and networking opportunities. While many of the sessions are...
Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded-criteria donors
A recently released article by Savoye et al. used the data collected by The French National Transplant Registry (CRISTAL) following the implementation of a nationwide hypothermic machine perfusion (HMP) program for extended criteria donor (ECD) kidney transplants. The...
A recent review article by Dutkowski et al. looked at the evolving evidence for machine perfusion in liver transplantation. They explored the evidence and requirements for both HMP and NMP. They presented the following information: That endpoints need to be strictly...